On Wednesday morning, CVS Health ($CVS@US) reported their quarterly earnings, including a $2.42 earnings per share that beat analyst’s projections by 17.48%. CVS had sales of $72.6 billion for Q2, topping the projections by 3.55% and increasing 11.11% year over year. Shares of CVS were trading 4.13% lower at press time.
